Peptide Institute Inc.
Is this your company? Claim this profile
Drug Product
Excipients & Specialty Ingredients
Regulatory, Tech Transfer & Support Services
Company Overview
About
Peptide Institute Inc. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Rare Disease
Metabolic
Quick Facts
HQ:Japan
Founded:2012
Employees:2,353
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Drug Product
- Biologics Manufacturing
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Prefilled Syringe
Sterile Injectable
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval QFSTGP
PMDA · #APR-3L2B2FJF · 2019-11-01
Drug Approval 3N6EN2
Health Canada · #APR-LMHKM1IC · 2019-08-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-SO12FAT5
Issued: 2020-04-08
Expires: 2025-02-15
Health Canada GMP
Health Canada
Cert #: CERT-WH002DKT
Issued: 2020-05-28
Expires: 2025-03-15
Loading CDMO intelligence...
Key facts about Peptide Institute Inc.
- Peptide Institute Inc. is headquartered in Japan.
- Peptide Institute Inc. was founded in 2012.
- Peptide Institute Inc. has 2,353 employees.
- Peptide Institute Inc.'s capabilities include Biologics Drug Substance, Biologics Drug Product and Biologics Manufacturing.
Find CDMOs like Peptide Institute Inc.
Directory pages this company appears in, each with the full list of matching manufacturers.